Therefore, the upregulation of PD-L1 expression by MM cells by panobinostat is likely independent of activation of the STAT1-IRF1 pathway, and may be due to histone acetylation of a PD-L1 gene promoter as demonstrated in different types of cancer cells [12, 18]. The gene discussed is IRF1; the disease is Miyoshi myopathy.